Literature DB >> 22709939

The risk of cancer is not increased in patients with multiple kidney transplantations.

Hermina C Wisgerhof1, Ron Wolterbeek, Geert W Haasnoot, Frans H J Claas, Johan W de Fijter, Rein Willemze, Jan N Bouwes Bavinck.   

Abstract

BACKGROUND: The aim of this study was to investigate whether the number of transplantations, as a marker of the graft rejection status of the patient, is associated with an increased risk of malignancies.
METHODS: In a cohort study, 1213 patients, receiving a kidney transplantation between 1966 and 1995 at the Leiden University Medical Center, were analyzed. All cutaneous squamous cell carcinoma and internal malignancies, which had developed between 1966 and 2007, were recorded. The influence of number of transplantations, age, sex and time on immunosuppression on the risk of squamous cell carcinoma and internal malignancies was investigated by time-dependent multivariate Cox's proportional hazard models.
RESULTS: Of the 1213 kidney transplant recipients, 319 received a second kidney, 78 a third; 13 of them a fourth and 4 of them a fifth transplantation. After adjustment for potentially confounding factors, including age, sex and years on immunosuppressive therapy we did not detect an increased risk of cancer in patients with multiple transplantations. On the contrary, patients with three or more transplantations had a 1.6-fold decreased risk of squamous cell carcinomas and a 3.6-fold decreased risk of internal malignancies.
CONCLUSION: We conclude that kidney transplant recipients with three or more transplantations do not have an increased risk of cutaneous squamous cell carcinoma and internal malignancies.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22709939     DOI: 10.1016/j.trim.2012.06.002

Source DB:  PubMed          Journal:  Transpl Immunol        ISSN: 0966-3274            Impact factor:   1.708


  1 in total

1.  Ovarian carcinosarcoma in a renal transplant recipient. A unique case of a rare tumor.

Authors:  S Vernadakis; D Moris; C Delimpalta; J Bokos; G Zavos
Journal:  Hippokratia       Date:  2014 Oct-Dec       Impact factor: 0.471

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.